Aurinia: Q4 Earnings Snapshot
VICTORIA, British Columbia (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Tuesday reported a loss of $26 million in its fourth quarter
By AP News
Published - Feb 28, 2023, 06:15 AM ET
Last Updated - Apr 03, 2024, 02:35 PM EDT
VICTORIA, British Columbia (AP) — VICTORIA, British Columbia (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Tuesday reported a loss of $26 million in its fourth quarter.
On a per-share basis, the Victoria, British Columbia-based company said it had a loss of 18 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 26 cents per share.
The biotechnology company posted revenue of $28.4 million in the period.
